NASDAQ:MASI Masimo (MASI) Stock Forecast, Price & News $163.30 -2.02 (-1.22%) (As of 06/2/2023 06:55 PM ET) Add Compare Share Share Today's Range$162.54▼$166.3050-Day Range$155.24▼$196.4752-Week Range$108.89▼$198.00Volume373,200 shsAverage Volume378,713 shsMarket Capitalization$8.62 billionP/E Ratio74.91Dividend YieldN/APrice Target$188.88 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainabilityProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability Masimo MarketRank™ ForecastAnalyst RatingModerate Buy2.88 Rating ScoreUpside/Downside15.7% Upside$188.88 Price TargetShort InterestHealthy2.17% of Float Sold ShortDividend StrengthN/ASustainability-0.86Upright™ Environmental ScoreNews Sentiment0.54Based on 14 Articles This WeekInsider TradingAcquiring Shares$1 M Bought Last QuarterProj. Earnings Growth11.55%From $4.76 to $5.31 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.60 out of 5 starsMedical Sector132nd out of 980 stocksElectromedical Equipment Industry3rd out of 22 stocks 2.4 Analyst's Opinion Consensus RatingMasimo has received a consensus rating of Buy. The company's average rating score is 2.88, and is based on 7 buy ratings, 1 hold rating, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $188.88, Masimo has a forecasted upside of 15.7% from its current price of $163.30.Amount of Analyst CoverageMasimo has only been the subject of 1 research reports in the past 90 days. Previous Next 3.0 Short Interest Percentage of Shares Shorted2.17% of the float of Masimo has been sold short.Short Interest Ratio / Days to CoverMasimo has a short interest ratio ("days to cover") of 2.9, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Masimo has recently increased by 23.61%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldMasimo does not currently pay a dividend.Dividend GrowthMasimo does not have a long track record of dividend growth. Previous Next 4.2 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreMasimo has received a 61.97% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is driven by its "ECG monitors" product. See details.Environmental SustainabilityThe Environmental Impact score for Masimo is -0.86. Previous Next 3.1 News and Social Media Coverage News SentimentMasimo has a news sentiment score of 0.54. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 14 news articles for Masimo this week, compared to 7 articles on an average week.Search Interest8 people have searched for MASI on MarketBeat in the last 30 days. This is an increase of 60% compared to the previous 30 days.MarketBeat Follows7 people have added Masimo to their MarketBeat watchlist in the last 30 days. This is an increase of 40% compared to the previous 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Masimo insiders have bought more of their company's stock than they have sold. Specifically, they have bought $1,000,323.00 in company stock and sold $0.00 in company stock.Percentage Held by InsidersOnly 9.70% of the stock of Masimo is held by insiders.Percentage Held by Institutions87.67% of the stock of Masimo is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 2.5 Earnings and Valuation Earnings GrowthEarnings for Masimo are expected to grow by 11.55% in the coming year, from $4.76 to $5.31 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Masimo is 74.91, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 135.16.Price to Earnings Ratio vs. SectorThe P/E ratio of Masimo is 74.91, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 134.31.Price to Book Value per Share RatioMasimo has a P/B Ratio of 6.48. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Masimo (NASDAQ:MASI) StockMasimo Corp. is a global technology company, which engages in the development, manufacture, and marketing of patient monitoring technologies, and automation and connectivity solutions. Its products include remote patient monitoring, connectivity, and hospital automation solutions, including Masimo Patient SafetyNet, Masimo Patient SafetyNet Surveillance, Masimo SafetyNet, Masimo SafetyNet-Open, Replica, Iris, MyView, UniView, Uniview: 60, Trace, Masimo Sleep, Centroid, and Bridge. The company was founded by Joe E. Kiani in May 1989 and is headquartered in Irvine, CA.Read More Receive MASI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Masimo and its competitors with MarketBeat's FREE daily newsletter. Email Address MASI Stock News HeadlinesJune 2, 2023 | businesswire.comCORRECTING and REPLACING Masimo Board of Directors Authorizes Appointment of Michelle Brennan as Sixth Director Pending Stockholder Approval of Board Expansion and Election of ...June 2, 2023 | finance.yahoo.comMasimo Board of Directors Authorizes Appointment of Michelle Brennan as Sixth Director Pending Stockholder Approval of Board Expansion and Election of Company NomineesJune 5, 2023 | Edge On The Street (Ad)AI is Unstoppable. Now Is The Time!AI, or Artificial Intelligence, is all the rage right now. AI technologies are empowering users in every industry to increase sales, efficiency, and productivity. It's truly a case of adapt or fail.June 2, 2023 | msn.comMasimo's Proxy Battle With Politan Capital: Activism for Positive Change or Disruption?June 1, 2023 | finance.yahoo.comFounder of Masimo Joseph Kiani Buys More StockJune 1, 2023 | finance.yahoo.comFounder of Masimo Joseph Kiani Buys More Stock \June 1, 2023 | finanznachrichten.deRoyal Philips: Philips and Masimo introduce new, advanced monitoring capabilities to Philips high acuity patient monitorsJune 1, 2023 | finance.yahoo.comMasimo Board of Directors Sets the Record Straight on False and Misleading ClaimsJune 5, 2023 | Edge On The Street (Ad)AI is Unstoppable. Now Is The Time!AI, or Artificial Intelligence, is all the rage right now. AI technologies are empowering users in every industry to increase sales, efficiency, and productivity. It's truly a case of adapt or fail.June 1, 2023 | americanbankingnews.comJoe E. Kiani Purchases 6,365 Shares of Masimo Co. (NASDAQ:MASI) StockMay 31, 2023 | finance.yahoo.comMasimo Files Investor Presentation Highlighting Track Record of Success, Compelling Strategy, Responsive Governance Changes and Risks Posed by Quentin Koffey’s AgendaMay 30, 2023 | finance.yahoo.comPolitan Releases Investor Presentation Detailing Why New Directors Are Needed on the Masimo Board and Responds to Company’s Disingenuous ClaimsMay 27, 2023 | americanbankingnews.comMasimo Co. Forecasted to Post Q2 2023 Earnings of $0.99 Per Share (NASDAQ:MASI)May 26, 2023 | businesswire.comMasimo Announces Major Expansion of the HEOS ® PlatformMay 26, 2023 | finance.yahoo.comZacks Industry Outlook Highlights Hologic, Masimo and IntegerMay 26, 2023 | finance.yahoo.comMasimo Board of Directors Files Definitive Proxy and Issues Letter to StockholdersMay 25, 2023 | finance.yahoo.comMasimo's (MASI) Platform Expansion to Boost Patient MonitoringMay 24, 2023 | finance.yahoo.comMasimo Announces Major Expansion of the HEOS® PlatformMay 23, 2023 | finance.yahoo.comDown -16.93% in 4 Weeks, Here's Why Masimo (MASI) Looks Ripe for a TurnaroundMay 23, 2023 | benzinga.comPolitan Calls on Shareholders to Elect Independent Oversight to Masimo's BoardMay 23, 2023 | finance.yahoo.comPolitan Calls on Shareholders to Elect Independent Oversight to Masimo’s BoardMay 18, 2023 | americanbankingnews.comStockNews.com Initiates Coverage on Masimo (NASDAQ:MASI)May 16, 2023 | markets.businessinsider.comBTIG Releases a Buy Rating on Masimo (MASI)May 15, 2023 | americanbankingnews.comMasimo Co. (NASDAQ:MASI) Receives $188.88 Average PT from AnalystsMay 12, 2023 | finance.yahoo.comOrange County Business Journal Names Masimo’s Micah Young CFO of the YearMay 12, 2023 | americanbankingnews.comMasimo (NASDAQ:MASI) Shares Gap Down to $184.25May 12, 2023 | finance.yahoo.comDoes The Market Have A Low Tolerance For Masimo Corporation's (NASDAQ:MASI) Mixed Fundamentals?See More Headlines MASI Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart MASI Company Calendar Last Earnings5/09/2023Today6/05/2023Next Earnings (Estimated)8/08/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Electromedical equipment Sub-IndustryHealth Care Equipment SectorMedical Current SymbolNASDAQ:MASI CUSIP57479510 CIK937556 Webwww.masimo.com Phone(949) 297-7000Fax949-297-7001Employees6,000Year Founded1989Price Target and Rating Average Stock Price Forecast$188.88 High Stock Price Forecast$207.00 Low Stock Price Forecast$150.00 Forecasted Upside/Downside+15.7%Consensus RatingModerate Buy Rating Score (0-4)2.88 Research Coverage8 Analysts Profitability EPS (Most Recent Fiscal Year)$2.18 Trailing P/E Ratio74.91 Forward P/E Ratio34.31 P/E GrowthN/ANet Income$143.50 million Net Margins5.16% Pretax Margin6.99% Return on Equity19.32% Return on Assets8.02% Debt Debt-to-Equity Ratio0.67 Current Ratio2.16 Quick Ratio1.30 Sales & Book Value Annual Sales$2.04 billion Price / Sales4.23 Cash Flow$7.43 per share Price / Cash Flow21.99 Book Value$25.45 per share Price / Book6.42Miscellaneous Outstanding Shares52,790,000Free Float47,672,000Market Cap$8.62 billion OptionableOptionable Beta0.87 Social Links Key ExecutivesJoe E. KianiChairman & Chief Executive OfficerBilal MuhsinChief Operating OfficerMicah YoungChief Financial Officer & Executive Vice PresidentYongsam LeeChief Information Officer & Executive VPAnand SampathExecutive VP-Operations & Clinical ResearchKey CompetitorsIntegerNYSE:ITGRCONMEDNYSE:CNMDInModeNASDAQ:INMDLivaNovaNASDAQ:LIVNTransMedics GroupNASDAQ:TMDXView All CompetitorsInsiders & InstitutionsProShare Advisors LLCSold 688 shares on 5/26/2023Ownership: 0.006%Joe E KianiBought 6,365 shares on 5/25/2023Total: $1.00 M ($157.16/share)Empower Advisory Group LLCBought 14,512 shares on 5/25/2023Ownership: 0.027%Toroso Investments LLCBought 9,830 shares on 5/23/2023Ownership: 0.019%Seaport Global Advisors LLCBought 1,230 shares on 5/23/2023Ownership: 0.006%View All Insider TransactionsView All Institutional Transactions MASI Stock - Frequently Asked Questions Should I buy or sell Masimo stock right now? 8 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Masimo in the last twelve months. There are currently 1 hold rating and 7 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" MASI shares. View MASI analyst ratings or view top-rated stocks. What is Masimo's stock price forecast for 2023? 8 equities research analysts have issued twelve-month price targets for Masimo's shares. Their MASI share price forecasts range from $150.00 to $207.00. On average, they expect the company's share price to reach $188.88 in the next year. This suggests a possible upside of 15.7% from the stock's current price. View analysts price targets for MASI or view top-rated stocks among Wall Street analysts. How have MASI shares performed in 2023? Masimo's stock was trading at $147.95 on January 1st, 2023. Since then, MASI shares have increased by 10.4% and is now trading at $163.30. View the best growth stocks for 2023 here. Are investors shorting Masimo? Masimo saw a increase in short interest in the month of May. As of May 15th, there was short interest totaling 1,070,000 shares, an increase of 23.6% from the April 30th total of 865,600 shares. Based on an average daily trading volume, of 369,600 shares, the days-to-cover ratio is presently 2.9 days. Currently, 2.2% of the shares of the company are short sold. View Masimo's Short Interest. When is Masimo's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 8th 2023. View our MASI earnings forecast. How were Masimo's earnings last quarter? Masimo Co. (NASDAQ:MASI) released its earnings results on Tuesday, May, 9th. The medical equipment provider reported $0.87 EPS for the quarter, topping the consensus estimate of $0.83 by $0.04. The medical equipment provider had revenue of $565 million for the quarter, compared to the consensus estimate of $557.87 million. Masimo had a trailing twelve-month return on equity of 19.32% and a net margin of 5.16%. The company's quarterly revenue was up 85.7% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.93 EPS. What ETFs hold Masimo's stock? ETFs with the largest weight of Masimo (NASDAQ:MASI) stock in their portfolio include Global X Telemedicine & Digital Health ETF (EDOC), First Trust Nasdaq Lux Digital Health Solutions ETF (EKG), Invesco DWA Healthcare Momentum ETF (PTH), First Trust Indxx Medical Devices ETF (MDEV), Global X Founder-Run Companies ETF (BOSS), ERShares Entrepreneurs ETF (ENTR), BlackRock Future Health ETF (BMED) and Neuberger Berman Disrupters ETF (NBDS). What guidance has Masimo issued on next quarter's earnings? Masimo updated its FY23 earnings guidance on Tuesday, May, 9th. The company provided EPS guidance of $4.70-4.80 for the period, compared to the consensus EPS estimate of $4.76. The company issued revenue guidance of $2.415-2.460 billion, compared to the consensus revenue estimate of $2.44 billion. What is Joe E. Kiani's approval rating as Masimo's CEO? 136 employees have rated Masimo Chief Executive Officer Joe E. Kiani on Glassdoor.com. Joe E. Kiani has an approval rating of 90% among the company's employees. What other stocks do shareholders of Masimo own? Based on aggregate information from My MarketBeat watchlists, some companies that other Masimo investors own include NVIDIA (NVDA), Netflix (NFLX), Shopify (SHOP), Okta (OKTA), PayPal (PYPL), Alibaba Group (BABA), Mastercard (MA), Trade Desk (TTD), Walt Disney (DIS) and Twilio (TWLO). What is Masimo's stock symbol? Masimo trades on the NASDAQ under the ticker symbol "MASI." Who are Masimo's major shareholders? Masimo's stock is owned by many different institutional and retail investors. Top institutional investors include FMR LLC (11.57%), BlackRock Inc. (11.30%), State Street Corp (3.24%), Liontrust Investment Partners LLP (1.80%), Geode Capital Management LLC (1.38%) and Farallon Capital Management LLC (1.20%). Insiders that own company stock include Adam Mikkelson, Anand Sampath, Bilal Muhsin, Craig B Reynolds, Joe E Kiani, Jon Coleman, Micah W Young, Tao Levy and Thomas Samuel Mcclenahan. View institutional ownership trends. How do I buy shares of Masimo? Shares of MASI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Masimo's stock price today? One share of MASI stock can currently be purchased for approximately $163.30. How much money does Masimo make? Masimo (NASDAQ:MASI) has a market capitalization of $8.62 billion and generates $2.04 billion in revenue each year. The medical equipment provider earns $143.50 million in net income (profit) each year or $2.18 on an earnings per share basis. How many employees does Masimo have? The company employs 6,000 workers across the globe. How can I contact Masimo? Masimo's mailing address is 52 DISCOVERY, IRVINE CA, 92618. The official website for the company is www.masimo.com. The medical equipment provider can be reached via phone at (949) 297-7000, via email at ekammerman@masimo.com, or via fax at 949-297-7001. This page (NASDAQ:MASI) was last updated on 6/5/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Masimo Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.